Featured Articles

- For Your Patients
- COVID-19
Cautious Optimism for Hospitalized COVID-19 Patients

Patients who were sedated and intubated during the first wave of COVID-19 recovered and improved—with time and supportive care.
- Policy and Practice
- Multiple Sclerosis
What's Behind the $85.4 Billion Cost of MS

Retail prescription prices drove the costs of drugs for multiple sclerosis to a high of approximmately $85.4 billion in the US.
- Then and Now
- Sleep Neurology
Those 'Tried and True' Options for Managing Sleep Disorders

Greater awareness of sleep disorders has prompted more people to seek treatment. What's changed in 20 years?

More Recent Coverage

Most Popular

Happening Now

Editor-in-Chief:
Joseph E. Safdieh, MD, FAAN
ISSN: 1533-7006
Online ISSN: 1548-7822
Issue Outline
Past Issues

Videos

See More Videos

Recent Coverage

Disease Mechanisms

- Disease Mechanisms
Blood Pressure Trajectories in Early Adulthood Associated with Cerebral Lesions and Brain Structure in Midlife

Policy and Practice

- Policy and Practice
Multiple Sclerosis Costs More Than $85 Billion Annually, New Study Finds: The Policy Changes That Could Fix That

For Your Patients

Then and Now

- Then and Now
More Options Are Available for Managing Sleep Disorders: When the ‘Tried and True’ Methods Are Best Options, Experts Say

Professionalism

Neurotech

- Neurotech
Brain Connectivity Predicts Outcomes After Neonatal Injury, Study Finds

Sections